Arformoterol Tartrate Suppliers & Bulk Manufacturers
Available Forms: solution for inhalation
Available Strengths: 15 mcg per 2 mL
Reference Brands: Brovana (USA/EU)
Category:
Respiratory Disorder
Arformoterol (Brovana) is a long-acting beta-2 adrenergic agonist (LABA) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways, leading to improved airflow and easier breathing. Arformoterol is administered via a nebulizer as a sterile solution, typically dosed at 15 mcg per 2 mL.
Arformoterol Tartrate is available in solution for inhalation
and strengths such as 15 mcg per 2 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Arformoterol Tartrate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Arformoterol Tartrate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing